These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 25439775)

  • 21. Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia.
    Kang J; Hennessy-Strahs S; Kwiatkowski P; Bermudez CA; Acker MA; Atluri P; McConnell PI; Bartoli CR
    Circ Res; 2017 Sep; 121(8):963-969. PubMed ID: 28729354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility.
    Bartoli CR; Hennessy-Strahs S; Gohean J; Villeda M; Larson E; Longoria R; Kurusz M; Acker MA; Smalling R
    Ann Thorac Surg; 2019 Jun; 107(6):1761-1767. PubMed ID: 30586577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
    Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
    BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemolysis and von Willebrand factor degradation in mechanical shuttle shear flow tester.
    Shiraishi Y; Tachizaki Y; Inoue Y; Hayakawa M; Yamada A; Kayashima M; Matsumoto M; Horiuchi H; Yambe T
    J Artif Organs; 2021 Jun; 24(2):111-119. PubMed ID: 33559766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
    Van Belle E; Rauch A; Vincentelli A; Jeanpierre E; Legendre P; Juthier F; Hurt C; Banfi C; Rousse N; Godier A; Caron C; Elkalioubie A; Corseaux D; Dupont A; Zawadzki C; Delhaye C; Mouquet F; Schurtz G; Deplanque D; Chinetti G; Staels B; Goudemand J; Jude B; Lenting PJ; Susen S
    Circ Res; 2015 Mar; 116(7):1193-201. PubMed ID: 25670067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device.
    Davis ME; Haglund NA; Tricarico NM; Keebler ME; Maltais S
    ASAIO J; 2014; 60(3):355-7. PubMed ID: 24614358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support.
    Nascimbene A; Hilton T; Konkle BA; Moake JL; Frazier OH; Dong JF
    J Heart Lung Transplant; 2017 Apr; 36(4):477-479. PubMed ID: 28325436
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual Variability in von Willebrand Factor Fragility in Response to Shear Stress: A Possible Clue for Predicting Bleeding Risk.
    Sakatsume K; Akiyama M; Sakota D; Hijikata W; Horiuchi H; Maruyama O; Saiki Y
    ASAIO J; 2022 Sep; 68(9):1128-1134. PubMed ID: 34967782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
    Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
    Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
    Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleeding.
    Hennessy-Strahs S; Kang J; Krause E; Dowling RD; Rame JE; Bartoli CR
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):196-204. PubMed ID: 35501195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices.
    Geisen U; Brehm K; Trummer G; Berchtold-Herz M; Heilmann C; Beyersdorf F; Schelling J; Schlagenhauf A; Zieger B
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shear stress and von Willebrand factor in health and disease.
    Tsai HM
    Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and breakdown of soluble ultralarge von Willebrand factor multimers.
    Turner N; Nolasco L; Moake J
    Semin Thromb Hemost; 2012 Feb; 38(1):38-46. PubMed ID: 22314602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of a Rotational Speed Modulation System Used With an Implantable Continuous-Flow Left Ventricular Assist Device on von Willebrand Factor Dynamics.
    Naito N; Mizuno T; Nishimura T; Kishimoto S; Takewa Y; Eura Y; Kokame K; Miyata T; Date K; Umeki A; Ando M; Ono M; Tatsumi E
    Artif Organs; 2016 Sep; 40(9):877-83. PubMed ID: 26750507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
    Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speed Reduction Does Not Restore High Molecular Weight von Willebrand Multimers During HeartMate II Support: An In Vivo Study.
    Saeed O; Rangasamy S; Reyes Gil M; Goldstein DJ; Billett HH; Jorde UP; Patel SR
    ASAIO J; 2018; 64(5):e123-e125. PubMed ID: 29863626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.